0001213900-24-077791.txt : 20240911 0001213900-24-077791.hdr.sgml : 20240911 20240911174626 ACCESSION NUMBER: 0001213900-24-077791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240909 FILED AS OF DATE: 20240911 DATE AS OF CHANGE: 20240911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Paul Edward CENTRAL INDEX KEY: 0001658544 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39082 FILM NUMBER: 241293421 MAIL ADDRESS: STREET 1: 300 EAST 56TH STREET, APT 19E CITY: NEW YORK, STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 2222 PONCE DE LEON BLVD. 3RD FLOOR CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 4 1 ownership.xml X0508 4 2024-09-09 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001658544 Kelly Paul Edward C/O RELMADA THERAPEUTICS, INC. 2222 PONCE DE LEON BLVD, 3RD FLOOR CORAL GABLES, FL 33134 1 0 0 0 0 Common Stock 2024-09-09 4 P 0 25000 2.59 A 212295 D The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.50 to $2.64 per share, inclusive. /s/ Paul Kelly 2024-09-11